Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-902P is a pseudogene in the human genome, structurally similar to U6 small nuclear RNA (snRNA), which is a component of the spliceosome responsible for pre-mRNA splicing[2][1][3]. As a pseudogene, RNU6-902P does not encode a functional RNA or protein and is not actively involved in cellular processes. Although some pseudogenes may influence cellular regulation through RNA-mediated mechanisms, there is no evidence that RNU6-902P has a functional or regulatory role. Therefore, it should not be classified as a receptor, enzyme, or therapeutic target[2][4].
None. No mechanisms of action for drugs targeting this pseudogene
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 902, pseudogene (RNU6-902P).